startups digital health weight loss glp-1 Software development for and Weightloss Clinics AI, Protein, and GLP-1s: What's

Understanding how these medications work is an important first step toward choosing the right approach

Silva, M

Over the 5-year follow-up, there was an all-cause increased mortality risk of 1.29-fold vs the normokalemia cohort (45% vs 37%), a 1.40-fold increased risk for major adverse cardiac events (MACEs) (60% vs 45%), a risk of 1.72 (34% vs 19%) for RAASi discontinuation, and a 1.94-fold higher risk of hospitalization with arrhythmia compared with the matched normokalemia cohort [20]

Normally, only 5-10% of hair is in this phase

Stenblom, E.-L., Montelius, C., stbring, K., Hkansson, M., Nilsson, S., Rehfeld, J

At a Glance What It Is & Composition Semaglutide is a single-molecule GLP-1 receptor agonist an analogue of human GLP-1 engineered for a long half-life (about a week), which is what allows once-weekly rather than daily dosing